Showing results (71-80 of 383) with videos related to

Sort By:
Pageof 39
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
Journal of the American Heart Association|October 30, 2018
Incidence of Cancer Treatment-Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic AgentsAndrew C Nickel, Akshar Patel, Nabil F Saba, et al.
Journal of Veterinary Internal Medicine|October 3, 2014
Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphomaM A Morges, J H Burton, C F Saba, et al.
Frontiers in Cardiovascular Medicine|March 30, 2023
Subject-specific factors affecting particle residence time distribution of left atrial appendage in atrial fibrillation: A computational model-based studySoroosh Sanatkhani, Sotirios Nedios, Prahlad G Menon, et al.
Oral Oncology|December 2, 2014
Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention"Nabil F Saba, Missak Haigentz, Jan B Vermorken, et al.
Advances in Therapy|March 19, 2017
Otorhinolaryngological Toxicities of New Drugs in OncologyDana M Hartl, Daphné Morel, Erika Saavedra, et al.
Biomarker Research|January 9, 2025
SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosisFanghui Chen, Liwei Lang, Jianqiang Yang, et al.
The Laryngoscope|October 27, 2020
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult PopulationAndrew Tkaczuk, Sumita Trivedi, Mayur D Mody, et al.
Pageof 39